ANAMBRA PHARMACEUTICAL MANUFACTURING PARK

WHERE MEDICINE ARE MADE AND NOT IMPORTED

This is the vision of Professor Charles Chukwuma Soludo CFR to create medium and high tech industrial Parks in Anambra State.

The Pharma park is a compact modern-day pharmaceutical industrial estate that will house pharmaceutical companies of varying capacities, service providers, and companies providing support services to share workstations and infrastructure.

 

Our Plan is to position Anambra as the next axis for Nigerian industrialization hub

– Prof. Charles C. Soludo

Our Defined Zones

Investment Benefits

1) To take advantage of the now!!
2) To rapidly position Anambra for the future.
3) To play in area of core strength of Ndi-Anambra (marketing, pharm tech, reach, passion etc)
4) Rapidly develop the agricultural input sector.
5) Provision of raw materials to the beverage industry.
6) To position Anambra in the world economic map.
1) $16 billion African pharmaceutical market.
2) $3billion Nigerian pharmaceutical (captured by cotecna) import market, over $2b local market and over $2m uncaptured (imported without proper declaration or no declaration at all).
3) The incubation hub for the future African boardroom tigers (top earners).
4) Pharmaceutical innovation and research centre for Africa R&D.
5) Early bird log in as African Pharmaceutical Market destination through AfCFTA.
5) Placement of Anambra State on the global economic map Rapid development of Agro sector.
The global pharmaceutical market has witnessed significant growth, with projected revenues reaching US$1,163.00bn in 2023. This growth is expected to continue, with a projected annual growth rate of 5.39% (CAGR 2023-2027), resulting in a market volume of US$1,435.00bn by 2027.

The United States leads in generating the highest revenue in the global market, with US$624.10bn expected in 2023.

In the African pharmaceutical market, the Serviceable Addressable Market size is estimated to be US$14.36bn in 2023, with an annual growth rate of 3.35% (CAGR 2023-2027), reaching a market volume of US$16.38bn by 2027.

Notably, approximately 70% of pharmaceutical products in Nigeria are imported, amounting to about US$1.36bn. The top segments for over-the-counter (OTC) pharmaceutical products include Cold & Cough Remedies, Hand Sanitizers, Vitamins & Minerals, Analgesics, Digestives & Intestinal Remedies, and Skin Treatment.

To combat counterfeiting and parallel imports, national drug enforcement agencies are increasingly requiring country-specific labeling. In Nigeria, all pharmaceutical products must include a local address on their packaging. The Nigerian government's efforts to crack down on counterfeit drugs and reduce medical tourism are significant driving factors for the country's pharmaceutical market.

Picture Gallery

parallax background
 

Pharma Park’s Key Infrastructures

 

The key infrastructural development will include:


Road Network


Water Supply and Sewage Facilities


Common Effluent Treatment Facilities


Telecom Network


Generation and Distribution of Power


Parks/
Recreational Centres


Regulatory Complex


Administrative blocks

parallax background
 

Key Stakeholders

Ogboji pharma park will partner with AFREXIM and pharma fund for the development of infrastructure.

Key stakeholders include Academia for research and development, Pharma manufacturers of all forms of medicines, Quality Control specialists, Regulatory agencies (NAFDAC, Customs, PCN), Supply chain experts, warehousing operators, logistics and distribution companies, Donor agencies (AFDB, World Bank, USAID, Global Fund etc.), Private sector investors, support services (banks, schools, hotels, hospitals, etc.), and utility providers (mobile/internet service providers, water, waste treatment and disposal companies, power companies, etc.)


Pharma Park’s
Location

FIND US HERE
The Ogboji pharma park is located in the Ogboji community in Orumba South LGA of Anambra State, South East, Nigeria. The proposed site for the manufacturing hub sits on 200 hectares of land area said to house over 100 pharmaceutical companies, schools, and recreational parks among others.
150 hectares of saleable plots will be set aside for industrial, residential, and commercial purposes, while 50 hectares categorized under nonsealable plots could be used for common facilities, open spaces, and green belts.


Invest Today